Amber Reck Atwater, MD
Sharon Jacob, MD
Loma Linda, CA
Cory Dunnick, MD
Brian Machler, MD
Florham Park, NJ
Jenny Murase, MD
Peggy Wu, MD
For a complete list of the Board of Directors, please click here.
The virtual ACDS 32nd Annual Meeting was a great success! Learn more about the great presentations, posters and exhibitors that are available for on-demand viewing until June 15th.
ACDS members - $150
Non-member physicians - $175
Nurse/PA - $100
Residents/Students - Free
Learn more about the educational content by clicking the button below.
The Alexander A. Fisher Resident Award is presented to the best oral presentation by a resident or medical student at the Scientific Session of the ACDS Annual Meeting.
The Fran Storrs Poster Award is presented to the top three research/review posters at the Scientific Session of the ACDS Annual Meeting.
All ACDS Annual Meeting attendees had an opportunity to participate in the popular Contact Allergen Bee sponsored by the ACDS Dermatitis Journal. Congrats to our winners!
The ACDS Presidential Awards are selected annually by the American Contact Dermatitis Society (ACDS) President, and is presented to individuals who have made significant contributions to the Society and the field of contact dermatitis over the last several years.
The following list represents ACDS 2021 Presidential Award recipients. Congratulations and thank you for your contributions to the Society.
For a complete list of all award winners, please visit our website.
ACDS wishes to thank the following sponsors for their generous support of the ACDS 32nd Annual Meeting.
ACDS is pleased to announce that Ponciano (Chito) D. Cruz, Jr., MD has been awarded Honorary Membership status within the Society for his vast contributions to ACDS and and the Dermatitis Journal.
Dr. Cruz served as Editor-in-Chief of the ACDS’s Journal from 1999 to 2020. During his tenure, the original American Journal of Contact Dermatitis became Dermatitis with a purview expanding beyond contact dermatitis to include atopic, occupational, and drug dermatitis, and a growing family of global societies that called it home (NACDG, ECDRG, ICDRG, SIDAPA). Dr. Cruz’s editorship culminated in Dermatitis achieving its highest Impact Factor (3.988) and a rank of 8th among 68 journals in dermatology.
At the ACDS, Dr. Cruz served on the Board of Directors and on several committees (Long-range Planning, Nominations, Publications, Scientific Program, Strategic Planning); his notoriety included creation of the Contact Allergen Bee.
Dr. Cruz resides in Dallas, Texas where he serves on faculty at The University of Texas Southwestern Medical Center as Distinguished Professor, Endowed Chair in honor of Paul Bergstresser, Residency Program Director, and Vice Chair of the Department of Dermatology. He is also Chief of Dermatology at the North Texas VA Medical Center.
He served as President of the Society for Investigative Dermatology and the Photomedicine Society, and founded the Dermatology Teachers Exchange Group. He has served on several editorial boards and NIH study sections, has been a consistent recipient of research grant awards from the NIH, DVA, DOD, and CPRIT, and is the author of over 200 peer-reviewed publications.
Each year, the ACDS Editorial/Publications Committee recognizes the top Dermatitis articles published in the previous calendar year. Eligible articles include original reviews and studies from the six print issues published within the previous calendar year. Awards are based on scientific contribution; clinical significance and impact on clinical practice and patient care; and innovation and evidence-based reasoning.
It is with great pleasure that ACDS would like to announce the 2020 Dermatitis Articles of the Year. Open access is granted until July 1st. Thank you to all the authors that contributed.
Jeanette R. Comstock, MD, and Margo J. Reeder, MD
Dermatitis. 31(2):106-111, March/April 2020
Jodie Raffi, BA, MD, Isabel Elaine Allen, PhD, and Nina Botto, MD
Dermatitis. 31(3):209-214, May/June 2020
Kevin K. Veverka, MD and Mark D. P. Davis, MD
Dermatitis. 31(1):36-41, January/February 2020
Anton C. de Groot, MD, PhD
Dermatitis. 31(1):13-35, January/February 2020
PaperPal Preflight: Artificial Intelligence comes to Dermatitis
During our recent 2021 ACDS Annual Meeting, the ACDS Annual Business Meeting was held during which I provided an update on the ACDS Dermatitis journal. One of the features I described was PaperPal Preflight, a service offered by Wolters Kluwer (our publisher) to authors who are submitting manuscripts for consideration for publication in Dermatitis. The idea behind this optional service focuses on quality assurance prior to the manuscript being processed for the peer review process. This service will tell you whether your manuscript is ready for submission to Dermatitis. The artificial intelligence instantly (literally minutes to complete the entire process) scans the manuscript for the most common errors and omissions. Important characteristics, such as language problems, whether the references are current, length of the abstract and manuscript, and other features (figure legends, figure and table citations, keywords, etc.), are studied by artificial intelligence. A report of errors found in the manuscript is then generated, which is free of charge. The author can then select to have the errors corrected by the artificial intelligence, which has a small fee of $25.00 to complete the corrections and describe omissions and formatting errors. Credit card billing for the full service is via a safe and secure 3rd party vendor. After the author accepts the corrections, they can then submit the manuscript using the Editorial Manager.
For the author, this service offers the advantage of a shorter time to decision, fewer re-submissions, and a better submission experience. For the editor, there are fewer desk rejections, less time per manuscript and a shorter time for publication. For the publisher, there is less cost associated with publishing manuscripts and less copy editing is necessary. This is version 1.0 of PaperPal Preflight, and we anticipate refinements of this service in the future.
The PaperPal Preflight service is now operational within the Dermatitis Editorial Manager. Simply log in as an author, and follow the instructions to prepare your manuscript for analysis prior to submission. We encourage authors to take advantage of this service, particularly those international authors for whom English is a second language, and for novices to the field of publication. Certainly, even the most senior authors may benefit from this service. Please contact the journal office if there are any questions. Good luck with your submissions to Dermatitis!
Membership Survey for subscribers of Dermatitis
This survey will be directed to members, digital only subscribers, and social media users. It will be distributed within the next few weeks. We urge our members to complete this survey, which is being developed in collaboration with Wolters Kluwer research team. In a few weeks, the survey will be arriving in your email inbox as a survey monkey link. We are interested in learning how useful Dermatitis is to your practice, how you utilize the journal, the importance of the print versus online versions of the journal, the website and the importance of social media in disseminating our message. Of critical importance is how we stand with regard to other competing dermatology journals such as Contact Dermatitis. The most important information we hope to gain is: How can the journal can do a better job of meeting your needs? This survey will be one of many opportunities for our members to provide critical feedback to further improve the journal.
As always, we welcome your feedback. Please take the time to complete this survey, as it provides us with critical information for decision making related to journal policies and features.
Anthony A. Gaspari, MD
ACDS joined the ranks of the American Medical Association (AMA) in 2018 upon being accepted as a member of the Specialty and Service Society (SSS). ACDS is now on the precipice of becoming a full voting member in the esteemed AMA House of Delegates (HOD) as we have submitted the requisite materials to take this next step. AMA HOD represents all 50 states and well over 100 specialty and service societies. SSS is the largest caucus in the AMA. An association like ACDS must first be represented in the SSS before becoming a full voting member in the HOD. The SSS meets twice annually in conjunction with the Interim and Annual Meetings of the HOD. An SSS member society must participate for three years before it is eligible to seek admission to the HOD. I have been honored to attend all the meetings as our representative since our admission into the SSS. As a caucus, the SSS meets and votes to support, amend, or oppose submitted resolutions or board reports and ACDS has a vote in this process. The resolutions which are submitted from a variety of sources including state medical societies and national specialty groups dictate the important policies of the AMA.
Because ACDS is a member of the AMA SSS we are also a member of the DSC within the AMA. Other DSC member dermatology-related groups include the American Academy of Dermatology Association, the American Society of Dermatopathology, the American Society of Dermatologic Surgery Association, the American College of Mohs Surgery, and a multitude of dedicated dermatologists who are members of state society AMA delegations. The DSC serves many important roles. Most importantly, the DSC submits important resolutions and strategizes on how to approach resolutions submitted by other organizations. It also promotes candidates from within the DSC to hold leadership roles in the AMA. DSC played a lead role in shaping recent AMA policy pertaining to our ability to buffer lidocaine, offer sound telemedicine policy, and provide fair exceptions to the burden of prior authorization for medications.
I hear all too often that the AMA is not relevant, but, on the contrary, it’s critically important for the ACDS to be involved and for our members to join and maintain membership in the AMA. Once ACDS is a full voting delegate member of the HOD, which I anticipate occurring at the June 2022 AMA Annual Meeting, we will also have representation at the all-important AMA CPT and RUC committees. As a full voting member, ACDS will be able to cast a vote on critically important AMA policy. It will also open opportunities for ACDS representatives to hold leadership roles within the AMA. DSC members currently hold important leadership roles at the AMA including Dr. Jack Resneck, Jr. - Chair of the AMA Board of Trustees-, Dr. Marta Van Beek - AMA Council on Legislation, and Dr. Adam Rubin – Secretary, Governing Council, SSS.
I am looking forward to representing ACDS at the fast-approaching AMA Virtual Annual HOD Meeting which will be held from June 12 - 16, 2021. I anticipate policy discussions on several key issues including mitigation from the new rules from Office of the National Coordinator on information blocking and our requirement to provide expedient patient access to laboratory results. There may also be discussions on updating the FD&C Cosmetic Act and policy on how best to approach personal care product safety.
On the coding and reimbursement front, we have been adjusting to the updates in the outpatient Evaluation and Management (E&M) codes, in conjunction with other dermatologic and medical societies. The AMA released technical edits to these codes in March to help further clarify some of the updated terminology. The other E&M families of codes will be undergoing a similar re-evaluation process, including the outpatient consultation codes, in the upcoming months.
Bruce A. Brod, MD, MHCI, FAAD
ACDS Representative, AMA Specialty and Service Society
Alexandra Flamm, MD, FAAD
Chair, ACDS Health Policy Committee
The ACDS is committed to advancing the care and understanding of dermatitis and allergy through the promotion of education, research and advocacy. As part of this initiative, ACDS offers education awards to help encourage research in these areas.
For more information or to apply for an award, click here.
Diversity, Equity, Inclusion, and Healthcare Disparities Award
Focuses on the pathophysiology, epidemiology, diagnosis, management or prevention of atopic or contact dermatoses and their associated morbidity
Clinical Research Award
Research awards for the purpose of relevant clinical studies directed toward the subject of contact dermatitis.
ACDS 2020-2021 Clinical Research Award Winners
Mentoring awards for the purpose of assisting young dermatologists including dermatology residents, dermatology fellows, or dermatologist up to 5 years out of residency to become leaders/experts in the field of contact dermatitis by acquiring additional academic skills which may not be available at their training institutions.
ACDS 2020-2021 Mentoring Award Winners
Career development awards for the purpose of providing financial support to ACDS members to help defray the cost of acquiring specific skills and knowledge to enhance their professional development in some aspect of contact dermatitis and/or occupational dermatology.
ACDS 2020-2021 Mid-Career Award Winner
Outcomes Research Award
Research awards with the purpose of establishing the value of expert specialist evaluation and management of chronic dermatitis.
ACDS 2020-2021 Outcomes Research Award Winner
These monthly virtual events are FREE to all ACDS members and residents. Registration is required.
BONUS - Select dates now offering FREE CME!
Have a colleague that might be interested in attending who is not an ACDS member? Be sure to invite them to attend. A non-refundable $25 registration fee will apply.
For more information on registering, please click on each banner below and register today. Questions? - Email us here.
ACDS | 555 East Wells Street, Suite 1100 | Milwaukee, WI 53202
Support ACDS with AmazonSmile
If you do not wish to be included in our mailing list, please forward this message to email@example.com.